At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
The Dow Jones Industrial Average rallied from a low of 12751.51 to a high of 12858, but the daily chart remains negative. The NASDAQ rallied from a low of 2920.54 to a high of 1940.28, but the
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. ASPiRA GenetiX testing offers both targeted and a more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment.
| Website: | www.aspirawh.com |
| Email: | Arr@lifesciadvisors.com |
| Main Phone: | +1 512 519-0400 |
| Address: | 12117 Bee Caves Road, Building Three |
| Address 2: | Suite 100 |
| State: | TX |
| City / Town: | Austin |
| Country: | US |
| Postal Code: | 78738 |
| Exchange: | NSC |
| CEO: | Valerie Palmieri |
| Employees: | 53 |
| NAICS: | Analytical Laboratory Instrument Manufacturing(334516) |
At www.ValuEngine.com we show that the Medical sector 13.6% overvalued with the medical Instruments industry 2.0% undervalued. All 12 stocks in today’s table have complete ValuEngine data and
The Dow Jones Industrial Average rallied from a low of 12751.51 to a high of 12858, but the daily chart remains negative. The NASDAQ rallied from a low of 2920.54 to a high of 1940.28, but the
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 10 | 20 |
| Number of Buys | 10 | 20 |
| Number of Sells | 0 | 0 |
| Net Activity | 5344264 | 8061903 |
| Last 10 Buys | Shares |
|---|---|
| Henri George Schuler | 1,000 |
| Henri George Schuler | 1,000 |
| Henri George Schuler | 1,000 |
| Jack W Schuler | 1,000 |
| Henri George Schuler | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Valerie Palmieri | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Carl Severinghaus | 1,000 |
| Carl Severinghaus | 1,000 |
| Carl Severinghaus | 1,000 |
| Gail S. Page | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
| Low Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
| Mean Target Price Estimate | 2.25 | 2.25 | 2.25 | 2.25 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 11/02/17 | 11/02/17 | 11/02/17 | 11/02/17 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-05-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 32 | 2018-05-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 11 | 2018-05-14 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 81 | 2018-05-11 |
| 10-K/A | Amendment to a previously filed 10-K | 29 | 2018-04-30 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 81 | 2018-04-27 |
| SC 13D/A | Amendment to a SC 13D filing | 10 | 2018-04-23 |
| SC 13D/A | Amendment to a SC 13D filing | 8 | 2018-04-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-04-19 |
| SC 13D/A | Amendment to a SC 13D filing | 10 | 2018-04-19 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 3 | 1 | 1 | 1 |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
